🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Based on the pediatric-inspired, PEG-L-asparaginase-intensified and MRD-dir...
Status
Unknown
Location
Department of Hematology, Nanfang Hospital
Start Date
2016-02-14
Trial ID
NCT03564704
Treatments Being Tested
This is a phase II study designed to investigate the combination of bortezo...
Status
Terminated
Location
Children's Mercy Hospital
Start Date
2015-07
Trial ID
NCT02535806
The purpose of this study is: 1. To compare priming with Granulocyte-Macro...
Status
Completed
Location
Multiple Locations
Start Date
1999-03
Trial ID
NCT00880243
Treatments Being Tested
The overall aim of this study is to determine if epigenetic priming with a ...
Status
Active Not Recruiting
Location
Children's Hospital of Central California
Start Date
2017-06-15
Trial ID
NCT03164057
This phase II trial studies the side effects and how well Vyxeos works in t...
Status
Recruiting
Location
UC Davis Comprehensive Cancer Center
Start Date
2021-01-29
Trial ID
NCT04049539
Treatments Being Tested
This research study investigates the tolerability of substituting two cycle...
Status
Recruiting
Location
Texas Children's Cancer and Hematology Center
Start Date
2025-10-22
Trial ID
NCT07059975
RATIONALE: Sometimes the cancer may not need treatment until it progresses....
Status
Withdrawn
Location
Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
Start Date
2008-09
Trial ID
NCT00723658
This open-label, non-randomized, phase II exploratory study aims to evaluat...
Status
Recruiting
Location
Blood diseases hospital
Start Date
2026-05-30
Trial ID
NCT07454226
This phase II trial studies the effect of CPX-351 followed by donor stem ce...
Status
Terminated
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2021-08-09
Trial ID
NCT04526288
This phase II trial studies the effect of adding pomalidomide to usual chem...
Status
Active Not Recruiting
Location
Emory University Hospital/Winship Cancer Institute
Start Date
2022-08-24
Trial ID
NCT04802161